PuroB3-hW

General Information


DRACP ID  DRACP02029

Peptide Name   PuroB3-hW

Sequence  FRVTXRTKXXKG

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  porcine cathelicidin peptide

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia IC50 ≥ 65 µM MTT assay 24h 1

Hemolytic Activity  RBC: IC50 ≥ 65 µM

Normal (non-cancerous) Cytotoxicity  PBMC: IC50 ≥ 65 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  X=HTrp=5-hydroxytryptophan

Chiral  L



Physicochemical Information


Formula  C48H79N17O9

Absent amino acids  ACDEHILMNPQSWY

Common amino acids  X

Mass  156463

Pl  12.53

Basic residues  4

Acidic residues  0

Hydrophobic residues  2

Net charge  4

Boman Index  -3812

Hydrophobicity  -96.67

Aliphatic Index  24.17

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32126228

Title  Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin

Doi 10.1016/j.bbamem.2020.183228

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.